CI vs HIMS vs VRHI Stock Comparison

Cigna, Hims & Hers Health and Veri MedTech Holdings Prices as of Nov 16, 2026 Peers: Industry group
CI Cigna Group
$300.17 -0.8% 1M +11.3% 1Y
Market cap
$77.24B
P/E
12.9x
Revenue (TTM)
$286.32B
Div. yield
0.02%
Managed Care Healthcare
4 wins

Head to Head

8 decided of 12

Cigna leads on 4 of the 12 questions below (Cigna 4, Veri MedTech Holdings 3, Hims & Hers Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCIHIMSVRHILeader
Larger companyMarket capitalisation $77.24B $4.13B $35.28M CI
Cheaper on earningsLower P/E, profitable companies only 12.9x -21.7x -17.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 9.1x — — –
Faster revenue growthRevenue growth, trailing twelve months +6.8% +29.8% -31.2% HIMS
More profitableNet margin, trailing twelve months 2.1% -6.6% -22.5% CI
Better return on capitalReturn on invested capital 10.4% — — –
Less leveragedLower net debt / EBITDA 1.9x — -0.1x VRHI
Higher dividend yieldTrailing dividend yield 0.02% 0.00% — –
Better 1-year returnPrice return, last 12 months +11.3% -49.8% +221.9% VRHI
Better 5-year returnAnnualised price return, 5 years +6.7%/yr +18.0%/yr +33.5%/yr VRHI
Less volatileAnnualised volatility, 1 year 27.1% 91.2% 158.2% CI
Higher overall scoreMean of the five percentile scores vs peers 63/100 38/100 21/100 CI

Percentile Scorecard

CIHIMSVRHI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCIHIMSVRHI
Valuation 89 #4 of 27 36 #64 of 99 19 #80 of 99
Growth 40 #16 of 26 24 #68 of 89 31 #62 of 89
Profitability 68 #9 of 26 33 #62 of 92 31 #64 of 92
Financial Health 32 #18 of 26 20 #83 of 103 5 #98 of 103
Shareholder Returns 88 #3 of 18 76 #16 of 63 –
Overall 63 38 21
  • CI ranked among 27 companies in Healthcare Payers and Distributors
  • HIMS ranked among 103 companies in Healthcare Providers
  • VRHI ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCIHIMSVRHISPY
1 month -0.8%-33.9%0.0% -3.0%
3 months +9.0%-35.2%+87.7% -4.2%
6 months +4.7%-16.7%+283.5% +0.2%
Year to date +9.1%-42.8%+252.8% +8.5%
1 year +11.3%-49.8%+221.9% +10.1%
3 years +6.2%+148.5%+1,160.0% +64.1%
3 years, per year +2.0%+35.5%+132.8% +18.0%
5 years +38.3%+128.6%+324.0% +58.1%
5 years, per year +6.7%+18.0%+33.5% +9.6%
10 years +117.7%—+1,060.5% +239.6%
10 years, per year +8.1%—+27.8% +13.0%

Risk

MeasureCIHIMSVRHISPY
Volatility, 1Y 27.1%91.2%158.2% 13.8%
Downside volatility, 1Y 26.8%86.9%327.7% 14.2%
Beta vs S&P 500, 1Y 0.072.59-0.34 1.00
Return / volatility, 1Y 0.42-0.551.40 0.74
Max drawdown, 5Y -33.4%-78.9%-87.3% -25.4%
From 52-week high -5.0%-53.6%-26.5% -5.0%
52-week high $315.88$40.02$6.00 $779.14
52-week low $258.08$14.52$0.97 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCIHIMSVRHI
P/E now vs peer median 13.0xmedian 25.2x -24.2xmedian 22.4x -17.0xmedian 22.4x
P/S now vs peer median 0.3xmedian 0.4x 1.6xmedian 1.3x 3.8xmedian 1.3x
EV/EBITDA now vs peer median 8.1xmedian 14.5x -33.4xmedian 14.2x -17.9xmedian 14.2x
P/FCF now vs peer median 9.5xmedian 16.5x 145.7xmedian 19.0x 149.3xmedian 19.0x
P/B now vs peer median 1.8xmedian 2.7x 13.0xmedian 2.6x -12.9xmedian 2.6x
PEG now vs peer median 1.59median 1.72 0.35median 0.84 —median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCIHIMSVRHI
Revenue $286.32B $2.87B $9.21M
Gross profit $59.13B $1.83B $6.94M
Operating income $9.78B -$232.48M -$1.99M
Net income $6.71B -$190.81M -$2.07M
Free cash flow $8.27B $31.68M $236.34K
R&D – $212.19M –
EPS (diluted) $22.71 $-0.82 –
Cash & equivalents $6.19B $605.60M –
Total debt $31.14B – $101.39K
Shares (diluted) 263.79M 233.82M –
Enterprise value $46.10B $1.25B $35.28M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCIHIMSVRHI
P/E 13.0x -24.2x -17.0x
P/FCF 9.5x 145.7x 149.3x
P/Operating cash flow 8.3x 25.6x 149.3x
P/S 0.3x 1.6x 3.8x
P/B 1.8x 13.0x -12.9x
P/Tangible book 4.6x -110.0x -12.9x
EV/EBITDA 8.1x -33.4x -17.9x
EV/EBIT 10.4x -16.8x -17.8x
EV/Revenue 0.4x 1.4x 3.8x
EV/FCF 12.4x 123.2x 149.7x
EV/Operating cash flow 10.8x 21.7x 149.7x
PEG (3Y EPS CAGR) 1.59 0.35 –

Growth

14 metrics
MetricCIHIMSVRHI
Revenue growth (1Y) 6.8% 29.8% -31.2%
Revenue CAGR (3Y) 14.7% 53.6% –
Gross profit growth (1Y) -4.4% 10.4% -30.5%
Gross profit CAGR (3Y) -0.1% 41.7% –
Operating income growth (1Y) 8.3% -302.1% -103.2%
Operating income CAGR (3Y) 5.9% -78.8% –
Net income growth (1Y) 2.4% -242.6% -91.6%
Net income CAGR (3Y) 6.9% -74.8% –
EPS growth (1Y) -1.2% -251.7% –
EPS CAGR (3Y) 8.2% -68.7% –
Operating cash flow growth (1Y) 8.8% -44.6% 660.4%
Operating cash flow CAGR (3Y) -8.8% 59.0% –
Free cash flow growth (1Y) 11.1% -76.3% 728.5%
Free cash flow CAGR (3Y) -8.8% -3.1% –

Profitability

14 metrics
MetricCIHIMSVRHI
Gross margin 20.7% 63.8% 75.3%
EBITDA margin 4.4% -4.1% -21.5%
Operating margin 3.4% -8.1% -21.5%
Pretax margin 2.9% -7.7% -22.1%
Net margin 2.1% -6.6% -22.5%
FCF margin 2.9% 1.1% 2.6%
Operating cash flow margin 3.3% 6.3% 2.6%
Return on equity 15.5% -65.9% –
Return on assets 4.3% -6.2% -1,064%
Return on invested capital 10.4% – –
Return on capital employed 9.6% -10.8% –
Asset turnover 1.8x 0.8x 49.2x
Cash conversion (OCF / net income) 1.4x -0.9x -0.1x
Stock comp / revenue – 6.2% 14.8%

Financial Health

11 metrics
MetricCIHIMSVRHI
Debt / assets 19.8% – 59.3%
Debt / equity 0.7x – 0.0x
Net debt / EBITDA 1.9x – -0.1x
Debt / FCF 3.8x – 0.4x
Liabilities / assets 72.3% 90.0% 1,698%
Equity / assets 27.7% 10.0% -1,598%
Interest coverage – – -28.9x
Current ratio 0.8x 0.9x 0.0x
Quick ratio 0.7x 0.8x –
Cash ratio 0.1x 0.5x –
Altman Z-score 2.82 1.29 -38.09

Shareholder Returns

7 metrics
MetricCIHIMSVRHI
Dividend yield 2.1% – –
Net buyback yield 1.7% 1.3% –
Shareholder yield 3.8% 1.3% –
Payout ratio (earnings) 24.3% – –
Payout ratio (FCF) 19.7% – –
Dividend growth (1Y) 2.1% – –
Dividend CAGR (3Y) 4.6% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCIHIMSVRHI
Forward P/E 9.1xFY2026 – –
EPS, next fiscal year $32.48FY2026 $-0.93FY2026 –
EPS growth, next FY +8.8%FY2026 -282.4%FY2026 –
EPS growth, the year after +8.7% – –
Revenue, next fiscal year $304.63BFY2026 $3.28BFY2026 –
Revenue growth, next FY +10.8%FY2026 +39.8%FY2026 –
Revenue growth, the year after -6.8% +25.4% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCIHIMSVRHI
Held by institutions 89.7% 69.3% –
Institutions holding 1,704 510 –
Change in shares held, QoQ +0.9% +4.4% –
Institutions buying 838 325 –
Institutions selling 576 130 –
Buyers to sellers 1.45 2.50 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CIHIMSVRHI
CI 1.00 -0.06 0.00
HIMS -0.06 1.00 -0.07
VRHI 0.00 -0.07 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CI, HIMS and VRHI?

Cigna (CI) is the largest by market capitalisation: Cigna (CI) $77.24B, Hims & Hers Health (HIMS) $4.13B, Veri MedTech Holdings (VRHI) $35.28M.

Which company is growing faster?

Hims & Hers Health (HIMS) grew revenue fastest over the trailing twelve months: Cigna (CI) +6.8%, Hims & Hers Health (HIMS) +29.8%, Veri MedTech Holdings (VRHI) -31.2%.

Which company is more profitable?

Cigna (CI) has the highest net margin (Cigna (CI) 2.1%, Hims & Hers Health (HIMS) -6.6%, Veri MedTech Holdings (VRHI) -22.5%).

Which stock has performed better?

Over the past year Veri MedTech Holdings (VRHI) returned the most: Cigna (CI) +11.3%, Hims & Hers Health (HIMS) -49.8%, Veri MedTech Holdings (VRHI) +221.9%. Over five years, Veri MedTech Holdings (VRHI) compounded fastest (Cigna (CI) +6.7%/yr, Hims & Hers Health (HIMS) +18.0%/yr, Veri MedTech Holdings (VRHI) +33.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cigna (CI) 0.02%, Hims & Hers Health (HIMS) 0.00%. Hims & Hers Health (HIMS) and Veri MedTech Holdings (VRHI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cigna (CI) has been the steadiest (Cigna (CI) 27.1%, Hims & Hers Health (HIMS) 91.2%, Veri MedTech Holdings (VRHI) 158.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CI, HIMS and VRHI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cigna (CI) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.